Google DeepMind's protein folding v3 can now design new proteins
AlphaFold 3 moves from prediction to creation. The implications for drug discovery are enormous.
Google DeepMind has released AlphaFold 3, and it represents a fundamental shift from protein structure prediction to protein design. The new model can generate novel protein structures optimized for specific functions.
From prediction to design
AlphaFold 1 and 2 answered the question "what shape does this protein take?" AlphaFold 3 answers "what protein shape do I need to achieve this function?" It is the difference between reading and writing.
Drug discovery implications
Early results suggest AlphaFold 3 could compress the protein engineering phase of drug discovery from years to weeks. Several pharmaceutical companies are already integrating the tool into their pipelines.
AI Reporter
Senior AI reporter covering research breakthroughs, industry trends, and the people building the future of intelligent systems. Previously at Wired and MIT Technology Review.
Liked this? You will love the briefing.
One email. Every morning. The tech that matters.